HIV-1 Diversity, Drug-Resistant Mutations, and Viral Evolution among High-Risk Individuals in Phase II HIV Vaccine Trial Sites in Southern China

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Qi, Haiyan ^a   Zhao, Ke ^b   Xu, Fei ^a   Zhang, Xuzhao ^a   Zhang, Zhiyong ^c   Yang, Li ^c   Li, Chunling ^c   Liang, Xu ^d   Guo, Weigui ^d   Chen, Shihai ^d   Liu, Zhihao ^d   Zhang, Wenyan ^b   Yu, Xiao Fang ^a,b,e  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

^d Nanning Center for Disease Control and Prevention   (China)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ENVELOPE PROTEIN;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; CHINA; ENVELOPE GENE; EVOLUTION; FEMALE; GENE MUTATION; GENE SEQUENCE; GROUP SPECIFIC ANTIGEN GENE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NUCLEOTIDE SEQUENCE; PHASE 2 CLINICAL TRIAL; SPECIES DIVERSITY; STRUCTURAL GENE; UNINDEXED SEQUENCE; VACCINE PRODUCTION; VIRUS GENE; VIRUS RECOMBINANT;

AIDS VACCINES; AMINO ACID SEQUENCE; CHINA; CLINICAL TRIALS, PHASE II AS TOPIC; DRUG RESISTANCE, VIRAL; EVOLUTION, MOLECULAR; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, PROTEIN; VIRAL PROTEINS;

EID: 84880286258     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068656     Document Type: Article

References (28)

1. Skar H, Hedskog C, Albert J, (2011) HIV-1 evolution in relation to molecular epidemiology and antiretroviral resistance. Ann N Y Acad Sci 1230: 108-118.
2. Teng T, Shao Y, (2011) Scientific approaches to AIDS prevention and control in China. Adv Dent Res 23: 10-12.
3. Beyrer C, Razak MH, Lisam K, Chen J, Lui W, et al. (2000) Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. Aids 14: 75-83.
4. Garten RJ, Lai S, Zhang J, Liu W, Chen J, et al. (2004) Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 33: 182-188.
5. Garten RJ, Zhang J, Lai S, Liu W, Chen J, et al. (2005) Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin Infect Dis 41Suppl 1: S18-24.
6. Yu XF, Chen J, Shao Y, Beyrer C, Lai S, (1998) Two subtypes of HIV-1 among injection-drug users in southern China. Lancet 351: 1250.
7. Yu XF, Chen J, Shao Y, Beyrer C, Liu B, et al. (1999) Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China. J Acquir Immune Defic Syndr 22: 180-188.
8. Piyasirisilp S, McCutchan FE, Carr JK, Sanders-Buell E, Liu W, et al. (2000) A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 74: 11286-11295.
9. Yu ES, Xie Q, Zhang K, Lu P, Chan LL, (1996) HIV infection and AIDS in China, 1985 through 1994. Am J Public Health 86: 1116-1122.
10. Laeyendecker O, Zhang GW, Quinn TC, Garten R, Ray SC, et al. (2005) Molecular epidemiology of HIV-1 subtypes in southern China. J Acquir Immune Defic Syndr 38: 356-362.
11. Zeng H, Sun Z, Liang S, Li L, Jiang Y, et al. (2012) Emergence of a New HIV Type 1 CRF01_AE Variant in Guangxi, Southern China. AIDS Res Hum Retroviruses 28: 1352-1356.
12. Su Q, Liang H, Cen P, Bi Z, Zhou P, (2012) HIV type 1 subtypes based on the pol gene and drug resistance mutations among antiretroviral-naive patients from Guangxi, Southern China. AIDS Res Hum Retroviruses 28: 725-728.
13. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.
14. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, et al. (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73: 152-160.
15. Bon I, Alessandrini F, Borderi M, Gorini R, Re MC, (2007) Analysis of HIV-1 drug-resistant variants in plasma and peripheral blood mononuclear cells from untreated individuals: implications for clinical management. New Microbiol 30: 313-317.
16. Kroodsma KL, Kozal MJ, Hamed KA, Winters MA, Merigan TC, (1994) Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and proviral DNA. J Infect Dis 170: 1292-1295.
17. Pang W, Zhang C, Duo L, Zhou YH, Yao ZH, et al. (2012) Extensive and complex HIV-1 recombination between B', C and CRF01_AE among IDUs in south-east Asia. AIDS 26: 1121-1129.
18. McClutchan FE, Carr JK, Murphy D, Piyasirisilp S, Gao F, et al. (2002) Precise mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China. AIDS Res Hum Retroviruses 18: 1135-1140.
19. Song YH, Meng ZF, Xing H, Ruan YH, Li XP, et al. (2007) Analysis of HIV-1 CRF07_BC gag p6 sequences indicating novel deletions in the central region of p6. Arch Virol 152: 1553-1558.
20. Yu XF, Liu W, Chen J, Kong W, Liu B, et al. (2002) Maintaining low HIV type 1 env genetic diversity among injection drug users infected with a B/C recombinant and CRF01_AE HIV type 1 in southern China. AIDS Res Hum Retroviruses 18: 167-170.
21. Tripathy S, Renjifo B, Wang WK, McLane MF, Bollinger R, et al. (1996) Envelope glycoprotein 120 sequences of primary HIV type 1 isolates from Pune and New Delhi, India. AIDS Res Hum Retroviruses 12: 1199-1202.
22. Shang H, Zhong P, Liu J, Han X, Dai D, et al. (2010) High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China. PLoS One 5: e10631.
23. Liu J, Zhang C, (2011) Phylogeographic analyses reveal a crucial role of Xinjiang in HIV-1 CRF07_BC and HCV 3a transmissions in Asia. PLoS One 6: e23347.
24. Gottlinger HG, Dorfman T, Sodroski JG, Haseltine WA, (1991) Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A 88: 3195-3199.
25. Yu XF, Matsuda Z, Yu QC, Lee TH, Essex M, (1995) Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation. J Gen Virol 76 (Pt 12): 3171-3179.
26. Yu XF, Dawson L, Tian CJ, Flexner C, Dettenhofer M, (1998) Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly. J Virol 72: 3412-3417.
27. Dettenhofer M, Yu XF, (1999) Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins. J Virol 73: 4696-4704.
28. Zhefeng M, Huiliang H, Chao Q, Jun S, Jianxin L, et al. (2011) Transmission of new CRF07_BC strains with 7 amino acid deletion in Gag p6. Virol J 8: 60.